- Home
- RL vs ICLR Comparison
RL vs ICLR Comparison
Compare RL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RL
- ICLR
- Stock Information
- Founded
- RL 1967
- ICLR 1990
- Country
- RL United States
- ICLR Ireland
- Employees
- RL N/A
- ICLR N/A
- Industry
- RL Apparel
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- RL Consumer Discretionary
- ICLR Health Care
- Exchange
- RL Nasdaq
- ICLR Nasdaq
- Market Cap
- RL 16.6B
- ICLR 13.7B
- IPO Year
- RL 1997
- ICLR 1998
- Fundamental
- Price
- RL $312.00
- ICLR $174.88
- Analyst Decision
- RL Strong Buy
- ICLR Buy
- Analyst Count
- RL 15
- ICLR 14
- Target Price
- RL $319.20
- ICLR $212.62
- AVG Volume (30 Days)
- RL 626.8K
- ICLR 984.3K
- Earning Date
- RL 08-07-2025
- ICLR 10-22-2025
- Dividend Yield
- RL 1.17%
- ICLR N/A
- EPS Growth
- RL 20.71
- ICLR 13.11
- EPS
- RL 12.52
- ICLR 9.73
- Revenue
- RL $7,285,900,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- RL $10.30
- ICLR N/A
- Revenue Next Year
- RL $4.80
- ICLR $1.73
- P/E Ratio
- RL $24.93
- ICLR $17.96
- Revenue Growth
- RL 9.61
- ICLR N/A
- 52 Week Low
- RL $169.93
- ICLR $125.10
- 52 Week High
- RL $321.77
- ICLR $313.51
- Technical
- Relative Strength Index (RSI)
- RL 62.38
- ICLR 53.80
- Support Level
- RL $292.90
- ICLR $161.01
- Resistance Level
- RL $299.95
- ICLR $182.67
- Average True Range (ATR)
- RL 7.00
- ICLR 5.39
- MACD
- RL 2.67
- ICLR -0.54
- Stochastic Oscillator
- RL 74.47
- ICLR 64.04
About RL Ralph Lauren Corporation
Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.